EDUCATIONPh.D., Louisiana State University, 2009, Adipocyte Biology
RESEARCH INTERESTSWhile obesity, or overall adiposity, is a risk factor for metabolic diseases, such as Type 2 diabetes, the distribution of adipose tissue may be a greater determinant of health risk. Dr. White's research focuses on examining the factors and mechanisms that influence human fat distribution, including the protective lower-body depots.
SELECTED PUBLICATIONSSanchez-Infantes D., White U.A., Elks C.M., Morrison R.F., Gimble J.M., Considine R.V., Ferrante A.W., Ravussin E., and Stephens J.M. (2014) Oncostatin M is produced in adipose tissue and is regulated in conditions of obesity and type 2 diabetes. J Clin Endocrinol Metab. 99(2), E217–E225. (PMC3913819)
Tchoukalova Y.D., Krishnapuram R., White U.A., Burk D, Fang X., Nijland M.J., and Nathanielsz P.W. (2014). Fetal baboon sex specific outcomes in adipocyte differentiation at 0.9 gestation in response to moderate maternal nutrient reduction. Int J Obes (Lond). 38(2):224-230. (PMC3883997)
White, U.A. and Tchoukalova, Y.D. (2014) Sex dimorphism and depot differences in adipose tissue function. Biochim Biophys Acta. 1842(3), 377-392.(PMC3926193)
White, U.A. and Tchoukalova, Y. (2012). Implications of 2H-labeling of DNA Protocol to Measure In Vivo Cell Turnover in Adipose Tissue. Adipocyte. 1(4), 242-245. (PMC3609104)
White, U.A., Stephens, J.M. (2011). The gp130 receptor cytokine family: Regulators of adipocyte development and function. Current Pharmaceutical Design. 17(4), 304-346. (PMC3119891)
White, U.A., Stewert, W.C., and Stephens, J.M. (2011) Gp130 cytokines exert differential patterns of crosstalk in adipocytes both in vitro and in vivo. Obesity. 19(5), 903-910. (PMC3080457)